Meridian Contrarian Fund

Holding/activity history for  Heron Therapeutics Inc. (HRTX)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2023   Q2 0 0 Sell 100.00% 0.35
2023   Q1 1,277,424 0.35 Add 115.05% 0.19 $1.51
2022   Q4 594,000 0.28 Reduce 42.05% 0.20 $2.50
2022   Q3 1,025,000 0.87 $4.22
2022   Q2 1,025,000 0.55 Add 17.55% 0.08 $2.79
2022   Q1 872,000 0.78 Add 24.04% 0.15 $5.72
2021   Q4 703,000 0.93 Reduce 6.98% 0.07 $9.13
2021   Q3 755,790 1.17 Add 57.20% 0.43 $10.69
2021   Q2 480,790 1.04 Add 79.54% 0.46 $15.52
2021   Q1 267,790 0.63 $16.21
2020   Q4 267,790 0.95 $21.17
2020   Q3 267,790 0.81 $14.82
2020   Q2 267,790 0.85 Reduce 15.73% 0.16 $14.71
2020   Q1 317,790 1.01 Reduce 5.92% 0.06 $11.74
2019   Q4 337,790 1.45 Reduce 20.10% 0.36 $23.50
2019   Q3 422,790 1.49 Add 27.04% 0.32 $18.50
2019   Q2 332,790 1.14 Add 144.70% 0.67 $18.59
2019   Q1 136,000 0.59 $24.44
2018   Q4 136,000 0.70 Buy 0.70 $25.94